scholarly article | Q13442814 |
P2093 | author name string | Hidemasa Oh | |
Shunji Sano | |||
Suguru Tarui | |||
P2860 | cites work | Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 |
RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 | ||
Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart Disease | Q34624729 | ||
Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation | Q34702433 | ||
Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. | Q35050037 | ||
Myocardial perfusion defects and associated systemic ventricular dysfunction in congenitally corrected transposition of the great arteries | Q35369247 | ||
Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells | Q35799278 | ||
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction | Q36349782 | ||
A strong regenerative ability of cardiac stem cells derived from neonatal hearts | Q36709832 | ||
Predictors of survival after single-ventricle palliation: the impact of right ventricular dominance. | Q37996136 | ||
Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis | Q38021450 | ||
Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. | Q38511389 | ||
Five- to fifteen-year follow-up after Fontan operation | Q38514255 | ||
Ultrastructure of crista supraventricularis muscle in patients with congenital heart diseases associated with right ventricular outflow tract obstruction | Q39726707 | ||
Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy | Q39864941 | ||
Follow-up of the patients after stem cell transplantation for pediatric dilated cardiomyopathy | Q42435066 | ||
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction | Q42644713 | ||
Survival and clinical course at Fontan after stage one palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduit | Q43704213 | ||
Intracoronary bone marrow cell application for terminal heart failure in children | Q44576825 | ||
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
Clinical profiles of adult patients with single ventricular physiology | Q48501311 | ||
Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. | Q50683671 | ||
Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training. | Q54444779 | ||
Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart. | Q54472692 | ||
Hypoplastic left heart syndrome | Q56519809 | ||
A regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells | Q58816143 | ||
Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy | Q58816169 | ||
Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up | Q73069787 | ||
Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling | Q79409654 | ||
Factors influencing early and late outcome following the Fontan procedure in the current era. The 'Two Commandments'? | Q79607720 | ||
Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery | Q80175472 | ||
Isolation and expansion of adult cardiac stem cells from human and murine heart | Q80837204 | ||
Noncultured cell transplantation in an ovine model of right ventricular preparation | Q81708831 | ||
Intramyocardial administration of autologous bone marrow mononuclear cells in a critically ill child with dilated cardiomyopathy | Q82065946 | ||
Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction | Q82750318 | ||
The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease | Q84160135 | ||
Peripheric stem cell transplantation in children with dilated cardiomyopathy: preliminary report of first two cases | Q84225516 | ||
Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience | Q84570135 | ||
Single right ventricles have impaired systolic and diastolic function compared to those of left ventricular morphology | Q84970618 | ||
P433 | issue | 2 | |
P304 | page(s) | 77-81 | |
P577 | publication date | 2014-04-01 | |
P1433 | published in | Methodist DeBakey cardiovascular journal | Q26841947 |
P1476 | title | Stem cell therapies in patients with single ventricle physiology | |
P478 | volume | 10 |
Q26799556 | Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease |
Q37670955 | Clinical cardiac regenerative studies in children |
Q34478846 | Hypoplastic left heart syndrome - unresolved issues |
Q39036971 | Managing heart failure in adults with congenital heart disease |
Q58562094 | Recent advances and challenges on application of tissue engineering for treatment of congenital heart disease |
Q26801514 | Stem cell therapy and tissue engineering for correction of congenital heart disease |
Q26786034 | Stem cell therapy for CHD: towards translation |
Q42587066 | Stem cells on a new stage: Treatment of hypoplastic left heart syndrome |
Q42583515 | The emergence of stem cell therapy for patients with congenital heart disease |
Search more.